UCB, a global biopharmaceutical company, today announced it will present 24 abstracts from its expansive neurology portfolio, regarding rare epilepsies Dravet syndrome (DS) and Lennox-Gastaut syndrome ...

This is the final chance to invest in the Mahila Samman Savings Scheme before it closes permanently. With high returns and ...

There are only a few days left for the new financial year 2025-26 to start. At the same time, many big changes are going to ...